Obermatt
See Similar Stocks →

Pulmonx

NSQ:LUNG · US7458481014
Health Care Equipment & SuppliesSmall

360

56
Profit price37
Owner Earnings Yield1
Dividend Yield1
Price/Sales83
EV / Gross Profit95
Price/Book100
Return on Capital27
Cash Return on Capital14
Return on Equity28
EBIT Margin19
Gross Profitability71
Accruals93
Owner Earnings Margin21
Sales growth21
Profit Growth15
Long-Term EPS Growth96
Reinvestment37
Price momentum17
Debt load28
Refinancing85
Debt Payback1
Liquidity20
Analyst ratings29
Opinion Changes7
Price Target Upside91
Market mood57
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Pulmonx doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded1995
Employees262
Websitepulmonx.com
ISINUS7458481014
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsChronic DiseasesPulmonologyRespiratoryBiomedical EngineeringDetectors, Sensors and MemsSensorsHealth CareMedical Device

Description

Pulmonx Corporation, a commercial-stage medical technology company, provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solution, which consists of the Zep…

Analysis

Middle-of-the-road

Pulmonx Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 4/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
19
2023202420252026

All-time high

85

Jan 2024

All-time low

6

Mar 2026

Average rank

32

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
83
51
22
11
Price/Earnings
53
18
18
18
Price/Book
100
63
56
48
Dividend Yield
1
1
1
1
Value (overall)
90
53
40
21

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Pulmonx with its peers
ResMed
NYQ:RMD
94
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
PROCEPT BioRobotics
NMQ:PRCT
19
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Tactile Systems Technology
NMQ:TCMD
98
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Edwards Lifesciences
NYQ:EW
55
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Pulse Biosciences
NAQ:PLSE
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Intuitive Surgical
NSQ:ISRG
60
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →